Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by BillB343on Mar 08, 2023 3:36pm
487 Views
Post# 35326622

Watched the Coffey interview

Watched the Coffey interviewCan all of you saying there is a ten billion dollar buyout coming explain why a BP is going to pay this for a company which at best has a drug that will simply extend life for a few extra months to a year?   I am not a barking dog.  I am not trying to steal your shares cheap.  I just want to know why this solution which remains unproven is so valuable?   I know if I was dying of some horrible cancer I would just want it over with.  Why linger for another 6 months to a year? In horrible pain?  This is why Pfizer passed here.  Pela is simply not that groundbreaking. Assuming it even works which I will assume for arguments sake.  So shareholders are sitting on dead money hoping for a wing and a prayer here.  Ok some of you may say 6 months to a year is a huge improvement.  I just don't see it that way. And likely pharma doesn't either. Hence the share price.  Ok block me say I am an idiot.  Say I am working for a big hedge fund desperate to get in here.  But after you say all that explain why I am wrong. 
<< Previous
Bullboard Posts
Next >>